ContextVision AB: Launch of offer to buy back own shares

13 Dec 2024 08:30 CET

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY IN UNITED STATES,
CANADA, AUSTRALIA, JAPAN OR ANY JURISDICTION IN WHICH THE DISTRIBUTION OR
RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR OTHER MEASURES.

Stockholm, Dec 13, 2024

ContextVision AB (publ) ("ContextVision" or the "Company") hereby launches an
offer to buy back up to 3,000,000 shares in the Company for an amount up to NOK
15,000,000 (the "Offer"). The purpose of the Offer is to acquire shares for use
in connection with the Company's Long-Term Incentive Program and/or to reduce
the capital of the Company. The Offer will be carried out based on the
authorisation granted to the board of directors at the Extraordinary General
Meeting held on November 20, 2024.

The Offer will be conducted as a reversed book-building process where the
Company, through Carnegie AS ("Carnegie"), will receive offers for desired
volumes for sale from the shareholders. All shareholders in the Company are
invited to sell shares in connection with the Offer, subject to the restrictions
set out herein.

The Company has mandated Carnegie as bookrunner for the Offer and shareholders
with interest to sell shares may contact Carnegie via email
contextvision@carnegie.no or by phone +47 22 00 93 40 before the end of the
Application Period (as defined below).

The Offer starts on December 16th, 2024 at 09:00 CET and will close no later
than December 17th, 2024 at 16:30 CET (the «Application Period»). The final
price offered by the Company and the allocation of tendered shares are expected
to be resolved by the Company on or about December 17th, 2024. The trade date is
expected to be on or about December 17th, 2024 and the settlement date is
expected to be on or about December 18th, 2024. The settlement will be conducted
on a normal delivery-versus-payment basis. The Company reserves the right to
extend the Application Period at its own discretion. If the Application Period
is extended, the other dates referred to herein may be amended accordingly.

The final purchase price per share will be set based on the sales orders
received at a level representing a satisfactory price and offering volume. The
purchase price per share shall not exceed NOK 10 or be less than NOK 5. The
final purchase price will be identical for all selling shareholders.

The Company will in the event of receiving offers exceeding a total of 3,000,000
shares, allocate shares at its discretion in accordance with the best interest
of the Company, taking into account the prices and volumes offered, with equal
treatment of the shareholders as the primary objective.

The Company reserves the right to, at its own discretion buy back fewer shares
or no shares at all, to terminate the Offer or make any amendments regarding the
volume or other terms of the Offer at any time until the time of completion of
the Offer.

This stock exchange announcement is published in accordance with the disclosure
requirements in Section 5-12 of the Norwegian Securities Trading Act. This stock
exchange announcement was published by Richard Hallström, CFO, on the time and
date provided.

For more information, please contact:

Richard Hallström, CFO richard.hallstrom@contextvision.com

About the ContextVision

ContextVision is a medical technology software company specialized in image
analysis and artificial intelligence. As the global market leader within image
enhancement, we are a trusted partner to leading manufacturers of ultrasound, X
-ray and MRI equipment around the world. Our expertise is to develop powerful
software products, based on proprietary technology and artificial intelligence
for image-based applications. Our cutting-edge technology helps clinicians
accurately interpret medical images, a crucial foundation for better diagnosis
and treatment. The company, established in 1983, is based in Sweden with local
representation in the U.S., Japan, China and Korea. ContextVision is listed on
the Oslo Stock Exchange under the ticker CONTX.

More information:
Access the news on Oslo Bors NewsWeb site